Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Biotechnology
  • Aura lays off 20% of workforce, rejigs C-suite amid R&D refocus on eye cancer

Aura lays off 20% of workforce, rejigs C-suite amid R&D refocus on eye cancer

August 11, 2026Posted inBiotechnology

Aura Biosciences is refocusing under its recently installed CEO, laying off 20% of its employees and overhauling its C-suite as it narrows its focus on ocular oncology.

Post navigation

Previous Post
marine-fungi-harbor-giant-endogenous-viral-remnants-that-co-diversified-with-their-hosts Marine fungi harbor giant endogenous viral remnants that co-diversified with their hosts
Next Post
AI Helps NUS Researchers Decode Singapore Shophouses’ Architectural DNA ai-helps-nus-researchers-decode-singapore-shophouses’-architectural-dna

Recent Posts

  • Xenon pauses phase 3 depression trials after psychosis events
  • BMS dumps $100M Orum degrader-antibody conjugate after glimpsing phase 1 data
  • Inflammation biotech Electra charges up with $350M from upsized IPO
  • Kidney Organoids Reveal Inflammatory Drivers of Diabetic Kidney Disease
  • Molecular Devices and STEMCELL Technologies Team Up to Automate Organoid Research

Archives

  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • March 2024
  • January 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top